Article
Chronic Liver Disease or Cirrhotic Patients Infected with SARS-CoV-2 Benefited from the Usual Oral Selective COX-2 Inhibitor
2023-09-01
Abstract excerpt
Background: The interdependent impacts between chronic liver disease (CLD) or cirrhosis and the common cold can deteriorate both of them due to the usual mild systemic inflammation. This retrospective study aimed to evaluate the effects of the usual oral cyclooxygenase-2 (COX-2) inhibitors on patients with CLD/cirrhosis.<br><br>Methods: The patients with prolonged intermittent oral selective COX-2 inhibitors (any...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 361ae653-af88-5c01-b7fd-e3ce1ea2b29c
- DOI
- 10.2139/ssrn.4555291